The role of recombinant epidermal growth factor and serotonin in the stimulation of tumor growth in a SCCHN xenograft model
Authors:
Open Access
- 6 July 2012
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 28 (3) , 785-790
Abstract
One challenge of squamous cell carcinoma of the head and neck (SCCHN) chemotherapy is a small percentage of tumor cells that arrest in the G0 phase of the cell cycle and are thus not affected by chemotherapy. This could be one reason for tumor recurrence at a later date. The recruitment of these G0-arresting cells into the active cell cycle and thus, proliferation, may increase the efficacy of chemotherapeutic agents. The aim of this study was to investigate whether stimulation with recombinant epidermal growth factor (EGF) or serotonin leads to an increased tumor cell proliferation in xenografts. Detroit 562 cells were injected into NMRI-Foxn1nu mice. Treatment was performed with 15 µg murine or human EGF, or 200 µg serotonin. The control mice were treated with Lactated Ringer's solution (5 mice/group). Tumor size was measured on days 4, 8 and 12 after tumor cell injection. The EGF stimulated mice showed a significantly higher tumor growth compared to the serotonin-stimulated mice and the untreated controls. In the present study, we show that it is possible to stimulate tumor cells in xenografts by EGF and thus, enhance cell proliferation, resulting in a higher tumor growth compared to the untreated control group. In our future investigations, we plan to include a higher number of mice, an adjustment of the EGF dosage and cell subanalysis, considering the heterogeneity of SCCHN tumors.Keywords
This publication has 20 references indexed in Scilit:
- The molecular biology of head and neck cancerNature Reviews Cancer, 2010
- Endothelial Cell-Initiated Signaling Promotes the Survival and Self-Renewal of Cancer Stem CellsCancer Research, 2010
- Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neckHead & Neck, 2010
- The epidermal growth factor receptor ligands at a glanceJournal of Cellular Physiology, 2008
- Enhancement of docetaxel efficacy in head and neck cancer treatment by G0 cell stimulationEuropean Journal of Cancer, 2007
- Enhanced tumour antiangiogenic effects when combining gefitinib with the antivascular agent ZD6126British Journal of Cancer, 2006
- Epidermal Growth Factor Receptor Biology in Head and Neck CancerJournal of Clinical Oncology, 2006
- Role of Epidermal Growth Factor Receptor Pathway–Targeted Therapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and NeckJournal of Clinical Oncology, 2006
- Epidermal growth factor stimulates the growth of A431 tumors in athymic miceCancer Letters, 2004
- Stimulation by EGF of the growth of EGF receptor‐hyperproducing tumor cells in athymic miceInternational Journal of Cancer, 1987